Clinical trial

Recent Advances in Treating Multiple Sclerosis: Efficacy, Risks and Place in Therapy.

Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.

Filed under: Drug and Alcohol Rehabilitation

Ther Adv Chronic Dis. 2013 Jan; 4(1): 45-51
Jeffery DR

The development of new pharmacologic agents for the treatment of multiple… Continue reading

CYP2C9 Mutation Affecting the Individual Variability of Warfarin Dose Requirement.

CYP2C9 Mutation Affecting the Individual Variability of Warfarin Dose Requirement.

Filed under: Drug and Alcohol Rehabilitation

Ann Rehabil Med. 2012 Dec; 36(6): 857-60
Kim YB, Ko MJ, Lee DG, Do JG, Hwang JH

Warfarin is a frequently prescribed anticoagulant… Continue reading

Addiction Rehab: mGlu(5) Negative Allosteric Modulators: A Patent Review (2010 – 2012).

mGlu(5) negative allosteric modulators: a patent review (2010 – 2012).

Filed under: Addiction Rehab

Expert Opin Ther Pat. 2013 Jan 22;
Emmitte KA

Introduction: The design and development of small molecule negative allosteric modulators (NAMs) of the metabotropic glutamate… Continue reading

Social Support and Functioning in a Patient With Spinal Cord Injury: The Role of Social Skills.

Social support and functioning in a patient with spinal cord injury: the role of social skills.

Filed under: Rehab Centers

Int J Rehabil Res. 2013 Jan 18;
Müller R, Rauch A, Cieza A, Geyh S

This study reports on… Continue reading

Rehab Centers: Patients’ Views on the Impact of Stroke on Their Roles and Self: A Thematic Synthesis of Qualitative Studies.

Patients’ views on the impact of stroke on their roles and self: A thematic synthesis of qualitative studies.

Filed under: Rehab Centers

Arch Phys Med Rehabil. 2013 Jan 18;
Satink T, Cup EH, Ilott I, Prins J, de Swart… Continue reading

Addiction Rehab: Inhibition of FAAH and Activation of PPAR: New Approaches to the Treatment of Cognitive Dysfunction and Drug Addiction.

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction.

Filed under: Addiction Rehab

Pharmacol Ther. 2013 Jan 16;
Panlilio LV, Justinova Z, Goldberg SR

Enhancing the effects of endogenously-released cannabinoid… Continue reading

The MTHFR C677T Variant Is Associated With Responsiveness to Disulfiram Treatment for Cocaine Dependency.

The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency.

Filed under: Addiction Rehab

Front Psychiatry. 2012; 3: 109
Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA

Objective: Disulfiram is a one of… Continue reading

Animal Models of Serotonergic Psychedelics.

Animal Models of Serotonergic Psychedelics.

Filed under: Drug and Alcohol Rehabilitation

ACS Chem Neurosci. 2013 Jan 16; 4(1): 33-42
Hanks JB, González-Maeso J

The serotonin 5-HT(2A) receptor is the major target of psychedelic drugs such as lysergic acid diethylamide… Continue reading

Pharmacological Roadmap for Treatment Resistant Depression – Part 2


 

Pharmacological Roadmap for Treatment Resistant Depression – Part 2 – medicaidmentalhealth.org Srijan Sen, MD, Ph.D. — Assistant Professor of Psychiatry, University of Michigan

 

Alkermes Maintains Fiscal 2013 View – Analyst Blog

Filed under: treatment resistant depression

Interesting candidates… Continue reading

Manual Linear Movements to Assess Spasticity in a Clinical Setting.

Manual Linear Movements to Assess Spasticity in a Clinical Setting.

Filed under: Rehab Centers

PLoS One. 2013; 8(1): e53627
Marinelli L, Trompetto C, Mori L, Vigo G, Traverso E, Colombano F, Abbruzzese G

In a clinical setting, where motor-driven… Continue reading